New Forest Labs pneumonia drug reaches goals – Forest Laboratories Inc said on Friday its experimental antibiotic proved to be at least as effective as an older medicine in pneumonia patients, reaching its main goal in two late-stage trials. Forest said its drug, ceftaroline, was well tolerated and met its primary goal of similar effectiveness and high clinical cure rates compared with ceftriaxone in patients with moderate to severe community-acquired, bacterial pneumonia requiring hospitalization…more
Pfizer manager sentenced for off-label Bextra promotions.
Subscribe to the Impactiviti blog via e-mail
Subscribe to the Impactiviti blog via RSS
Connect with Steve Woodruff